Program Overview

Mesrure Koseoglu · Nikolaos Grigoriadis · Serkan Ozben

The congress opens with a strategic regional perspective. Leading representatives present epidemiological insights, clinical realities, and system-level challenges across neighbouring countries. This session sets the foundation for sustainable collaboration, shared registries, and future multicenter research initiatives.

Multiple Sclerosis is no longer viewed as a uniform disease entity. This session examines immune heterogeneity, evolving diagnostic frameworks, and the complex mechanisms underlying progression. A focused expert discussion will connect pathobiology with practical clinical decision-making.

Salon A · Salon B · Salon C — Parallel sessions across three halls.

Precise imaging interpretation is essential in differentiating MS, NMOSD, and MOGAD. Moving beyond textbook descriptions, this session integrates bedside reasoning with advanced MRI pattern recognition. Interactive case discussions will sharpen diagnostic accuracy and therapeutic planning.

Rapid recognition is critical in neuro-ophthalmic disorders. This session addresses acute optic neuritis, MRI patterns that alter clinical management, and identifying red flags that signal systemic or neurological emergencies. Real-world cases will guide structured, evidence-based intervention.

Autoimmune encephalitis exemplifies the convergence of immunology and clinical neurology. This plenary lecture — delivered by Josep Dalmau — traces the pathway from antibody discovery to complex neuropsychiatric syndromes, addressing diagnostic refinement and contemporary treatment strategies.

Understanding the cellular drivers of MS opens new therapeutic horizons. This session explores the roles of B cell depletion, microglial activation, and oligodendrocyte biology in disease pathogenesis and remyelination. Emerging and established treatment strategies are examined in light of current scientific evidence.

The expanding use of immune checkpoint inhibitors and cell-based therapies has introduced a new spectrum of neurological complications. This session bridges oncology and neurology, examining the mechanisms and clinical indications of immunotherapies alongside the neurological syndromes they may provoke.

Behçet’s Disease remains one of the most complex multisystem inflammatory disorders in neuroimmunology. This keynote session explores systemic mechanisms, neurological phenotypes, and integrated treatment approaches, with particular emphasis on Neuro-Behçet’s management challenges.

Salon A · Salon B · Salon C — Parallel sessions across three halls.

Modern neuroimmunology depends on accurate biomarker integration. From CSF analysis and autoantibody profiling to OCT-based neurodegeneration assessment, this session highlights how laboratory and imaging data inform personalised care.

Infection-triggered autoimmunity represents a critical interface between systemic illness and neuroinflammation. This session analyses pathogenic mechanisms, diagnostic differentiation, and management strategies across post-infectious neurological syndromes, reinforced through case-based expert dialogue.

A sponsored satellite symposium examining the evolving science of B cell biology in MS progression and long-term disease control strategies.

Immune-mediated muscle and neuromuscular junction disorders demand precision in both diagnosis and treatment. This session provides an updated framework for inflammatory myopathies and myasthenia gravis, from conventional management to targeted immunological therapies — including early real-world experience with FcRn inhibitors.

Immune-mediated neuropathies present some of the most diagnostically and therapeutically demanding scenarios in neuroimmunology. This session addresses evolving criteria for CIDP, the emerging landscape of autoimmune nodopathies, and the multidisciplinary approach required for paraproteinemic and paraneoplastic neuropathies.

Complement activation has become a therapeutic turning point in neuroimmune disease. This session bridges molecular insight with clinical application, examining complement-targeted strategies in myasthenia gravis and NMOSD while clarifying mechanistic distinctions relevant to clinical practice.

Salon A · Salon B · Salon C · Salon D — Parallel sessions across four halls.

Managing neuroimmunological diseases across a woman’s reproductive life requires precision, balance, and individualised planning. This session addresses treatment optimisation in MS during pregnancy, the emerging roles of obesity and metabolism (including GLP-1 receptor agonists), and the often-overlooked impact of sleep on autoimmune neurological disease course.

A closed working meeting to establish the framework for a regional neuroimmunology network. Agenda includes proposals for joint multicenter datasets, future real-world clinical studies, and long-term collaboration structures.